We are live on
!
Find out more
FIM
Fernwood Investment Management Portfolio holdings
AUM
$288M
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+9.12%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$151M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
95.95%
Top 10 Holdings %
Top 10 Hldgs %
26.91%
Holding
142
New
142
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$5.36M |
| 2 |
Gilead Sciences
GILD
|
+$4.8M |
| 3 |
Safety Insurance
SAFT
|
+$4.56M |
| 4 |
CVS Health
CVS
|
+$4.1M |
| 5 |
Biogen
BIIB
|
+$3.56M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.47% |
| 2 | Energy | 15.56% |
| 3 | Industrials | 9.62% |
| 4 | Financials | 8.41% |
| 5 | Real Estate | 6.6% |
Similar funds
CIM
CSWM
WWP
GWM
FWM
MWS
AP
AA
Fernwood Investment Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Fernwood Investment Management, which disclosed 142 positions worth $151M. Its ten largest holdings account for 27% of the portfolio.
Its largest position is Portola Pharmaceuticals, Inc.: 220,582 shares worth $5.68M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Energy and Industrials.
- Fernwood Investment Management's largest Q4 2013 buy was Portola Pharmaceuticals, Inc.: 220,582 shares worth $5.68M.
- Fernwood Investment Management's ten largest holdings make up 27% of its $151M portfolio in Q4 2013.
- Fernwood Investment Management disclosed 142 positions in Q4 2013, its first 13F filing on record.
Based on Fernwood Investment Management's 13F filing for Q4 2013, filed 6 Feb 2014.